European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, falling 0.85% to 1,421.90 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet browser company Opera (OPRA) and software firm SAP (SAP), which rose 1.9% and 1.6%, respectively. They were followed by biopharmaceutical company MorphoSys (MOR) and 3D printer company Materialise (MTLS), which were up 1.1% and 1%, respectively.
The decliners from continental Europe were led by biopharmaceutical firm Cellectis (CLLS), which fell 4.2%, followed by pharmaceutical company Sanofi (SNY), which lost 3%. They were followed by pharmaceutical company Ascendis Pharma (ASND), which retreated 2.4%, and oil and gas company TotalEnergies (TTE), which was down 2.2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and TC Biopharm (TCBP), which increased 3.2% and 2.7%, respectively. Cruise line operator Carnival (CUK) was up 2.6% and biopharmaceutical firm Amarin (AMRN) added 1.6%.
The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN), which declined 4.3%, and then biotech firm Trinity Biotech, which lost 3.1%. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Adaptimmune Therapeutics (ADAP), which fell 3% and 2.5%, respectively.
Comments